Zileuton ER 600 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F1N39
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,190
Award facts
- Contract value 100% obligated
- $44,189.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $44,189.78 to AmerisourceBergen Drug Corp for the supply of Zileuton ER 600 mg tablets (120-count units). This non-set-aside contract was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zileuton ER is a leukotriene inhibitor used for asthma management, representing a routine pharmaceutical procurement supporting military and federal healthcare operations.
This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly fulfills competitively awarded orders for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle. The company's extensive portfolio with DLA demonstrates its established capability to meet federal pharmaceutical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1N39?
SPE2DR26F1N39 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F1N39 worth?
The government has obligated $44,190 on SPE2DR26F1N39.
Is contract SPE2DR26F1N39 an order under another contract?
Yes. SPE2DR26F1N39 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1N39 competed?
The extent of competition for SPE2DR26F1N39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award